2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: A dose-escalation, phase I study
    Journal Article

    Stathis, A.; Flinn, I. W.; Madan, S.; Maddocks, K.; Freedman, A.; Weitman, S.; Zucca, E.; Munteanu, M. C.; Lia Palomba, M.
    Investigational New Drugs (2018)

    Fulltext@MSK | Save
  • Peripheral T-cell lymphoma – Are we making progress?
    Journal Article

    Khan, N.; Ozkaya, N.; Moskowitz, A.; Dogan, A.; Horwitz, S.
    Best Practice and Research: Clinical Haematology (2018)

    Fulltext@MSK | Save
  • Rituximab plus lenalidomide in advanced untreated follicular lymphoma
    Journal Article

    Morschhauser, F.; Fowler, N. H.; Feugier, P.; Bouabdallah, R.; Tilly, H.; Palomba, M. L.; Fruchart, C.; Libby, E. N.; Casasnovas, R.O.; Flinn, I. W.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
    Journal Article

    Mato, A. R.; Thompson, M.; Allan, J. N.; Brander, D. M.; Pagel, J. M.; Ujjani, C. S.; Hill, B. T.; Lamanna, N.; Lansigan, F.; Jacobs, R.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
    Journal Article

    Straus, D. J.; Jung, S. H.; Pitcher, B.; Kostakoglu, L.; Grecula, J. C.; Hsi, E. D.; Schöder, H.; Popplewell, L. L.; Chang, J. E.; Moskowitz, C. H.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer
    Journal Article

    Varughese, T.; Taur, Y.; Cohen, N.; Palomba, M. L.; Seo, S. K.; Hohl, T. M.; Redelman-Sidi, G.
    Clinical Infectious Diseases (2018)

    Fulltext@MSK | Save
  • Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Journal Article

    Dang, N. H.; Ogura, M.; Castaigne, S.; Fayad, L. E.; Jerkeman, M.; Radford, J.; Pezzutto, A.; Bondarenko, I.; Stewart, D. A.; Shnaidman, M.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Cancer in people living with HIV, version 1.2018: Clinical Practice Guidelines in Oncology
    Journal Article

    Reid, E.; Suneja, G.; Ambinder, R. F.; Ard, K.; Baiocchi, R.; Barta, S. K.; Carchman, E.; Cohen, A.; Gupta, N.; Johung, K. L.; more...
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save
  • Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile
    Journal Article

    Querfeld, C.; Leung, S.; Myskowski, P. L.; Curran, S. A.; Goldman, D. A.; Heller, G.; Wu, X.; Kil, S. H.; Sharma, S.; Finn, K. J.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors
    Journal Article

    Derenzini, E.; Mondello, P.; Erazo, T.; Portelinha, A.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Valli, D.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save